Monitor for future funding announcements as the $50,000 bonus is tied to raising $5M in equity investments within 18 months; watch for potential share dilution from the 1.9 million stock options granted to the new CEO.
Price Chart
Executive Summary
Revium Rx appointed Amir Avraham as permanent CEO effective February 1, 2026, and Shlomi Schwartzblat as a director and chairman of the board. Avraham's employment agreement includes a monthly salary of NIS 55,000, eligibility for cash bonuses totaling up to $50,000, and stock options to purchase 1.9 million shares of common stock, subject to vesting and performance milestones.
Key Facts
- Amir Avraham appointed permanent CEO effective February 1, 2026, after serving as interim CEO since May 22, 2025
- Shlomi Schwartzblat appointed as director and chairman of the board
- Avraham's monthly salary set at NIS 55,000 (approximately $15,000 USD at current exchange rates)
- Avraham eligible for $50,000 cash bonus upon raising $5M in equity investments within 18 months of February 1, 2026
- Avraham granted options to purchase 1.9 million shares (1.3M initial grant, 300K for investment milestone, 300K for M&A milestone)
- Employment agreement includes 90-day notice period and 12-month non-compete clause
Financial Impact
Compensation package includes base salary of approximately $180,000 annually, potential $50,000 cash bonus, and stock options for 1.9 million shares subject to vesting and performance conditions
Risk Factors
- Potential dilution from issuance of up to 1.9 million stock options
- CEO's compensation is tied to fundraising success, which could incentivize dilutive capital raises
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-045633 |
| Document: ea0287042-8k_revium.htm | 0001213900-26-045633 |
| Document: 0001213900-26-045633-index-headers.html | 0001213900-26-045633 |
| Document: 0001213900-26-045633-index.html | 0001213900-26-045633 |
| Document: 0001213900-26-045633.txt | 0001213900-26-045633 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 1, 2026 21w ago | 8-K | $1.67 $1.67 | · 0.00% | ▲ +1.30% | $1.43 (−14.37%) |
Apr 20, 2026 27w ago | 8-K | $1.67 $1.67 | · 0.00% | ▼ −4.92% | $1.43 (−14.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers